Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Markowska

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Gynaecological Oncology|January 1, 1992
Value of CA 125 as a marker of ovarian cancerJ Markowska, G Manys, M Kubaszewska
European Journal of Gynaecological Oncology|January 1, 1992
CA 125 in monitoring clinical course in ovarian cancer patients. A prospective clinical studyJ Markowska, G Manys, Z Szewierski
Ginekologia Polska|September 1, 1993
[Side effects of drug treatment for ovarian cancer after administration of antiemetic drugs]J Markowska, E Wiese, M Markowski
Ginekologia Polska|January 1, 1992
[Role of second-look operations in women with ovarian cancer in complete remission]J Markowska, Z Szewierski, G Manys
Ginekologia Polska|August 1, 1980
[Correlation of skin tests with the peripheral blood T- and B-lymphocyte tests in malignant ovarian tumors]J Markowska, T Tomaszkiewicz, S Simm
Ginekologia Polska|June 1, 1993
[A case of vulvar dystrophy in a 18-year old patient lasting from her 10th-year of life]J Markowska, E Muszyńska-Wiese, G Zengteler
Nowotwory|April 1, 1987
[Usefulness of determining C-reactive protein levels for monitoring the patients with ovarian cancer]J Markowska, A Mackiewicz, J Gallas-Grala
Ginekologia Polska|April 1, 1996
[Role of second-look surgery in treatment of ovarian neoplasms]J Markowska, Z Szewierski, A Roszak, et al.
Ginekologia Polska|May 1, 1978
[Karyotype studies in abortion]J Markowska, T Rucki, S Simm, et al.
Neoplasma|January 1, 1990
CA 125 in monitoring chemotherapy of patients with ovarian cancer: early response to the treatmentJ Markowska, Z Kopczyński, G Manyś, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Gynaecological Oncology|January 1, 1992
Value of CA 125 as a marker of ovarian cancerJ Markowska, G Manys, M Kubaszewska
European Journal of Gynaecological Oncology|January 1, 1992
CA 125 in monitoring clinical course in ovarian cancer patients. A prospective clinical studyJ Markowska, G Manys, Z Szewierski
Ginekologia Polska|September 1, 1993
[Side effects of drug treatment for ovarian cancer after administration of antiemetic drugs]J Markowska, E Wiese, M Markowski
Ginekologia Polska|January 1, 1992
[Role of second-look operations in women with ovarian cancer in complete remission]J Markowska, Z Szewierski, G Manys
Ginekologia Polska|August 1, 1980
[Correlation of skin tests with the peripheral blood T- and B-lymphocyte tests in malignant ovarian tumors]J Markowska, T Tomaszkiewicz, S Simm
Ginekologia Polska|June 1, 1993
[A case of vulvar dystrophy in a 18-year old patient lasting from her 10th-year of life]J Markowska, E Muszyńska-Wiese, G Zengteler
Nowotwory|April 1, 1987
[Usefulness of determining C-reactive protein levels for monitoring the patients with ovarian cancer]J Markowska, A Mackiewicz, J Gallas-Grala
Ginekologia Polska|April 1, 1996
[Role of second-look surgery in treatment of ovarian neoplasms]J Markowska, Z Szewierski, A Roszak, et al.
Ginekologia Polska|May 1, 1978
[Karyotype studies in abortion]J Markowska, T Rucki, S Simm, et al.
Neoplasma|January 1, 1990
CA 125 in monitoring chemotherapy of patients with ovarian cancer: early response to the treatmentJ Markowska, Z Kopczyński, G Manyś, et al.
Pageof 9